Laura Easton speaks with Canadian Lawyer Magazine on AI hallucinations
Laura Easton was recently featured in Canadian Lawyer Magazine. She was interviewed by Jessica Mach on the growing number of Canadian court decisions involving AI-generated “hallucinations” in legal filings.
The article, “Body of court rulings on AI-hallucinated materials offer few new insights to lawyers using AI tools,” explores how courts across Canada are responding to cases where lawyers or self-represented litigants have submitted fictitious citations or inaccurate legal arguments generated by AI tools.
Easton explains that the presence of AI tools does not fundamentally change lawyers’ existing professional obligations. She emphasizes that AI should be treated like any other legal tool: something that requires careful oversight, verification and professional judgment.
“If your duty is to accurately represent the law before the court, and now you’re relying on something else to try to help you do that, what are you putting in place to ensure that you’re still meeting your duties now that you’re trying to do it with a new tool?”-Laura Easton
Read the full article on the Canadian Lawyer Magazine website.
Related News & Media
-
Reshika Dhir examines Canadian IP retention in TheFutureEconomy.ca
Principal Reshika Dhir recently wrote a piece featured in TheFutureEconomy.ca exploring a growing challenge in Canada’s innovation economy: the quiet migration of valuable intellectual property to ot...Read More -
Principals Noel Courage and Ainslie Parsons explore strategies for protecting new plant varieties across key markets
Principals Ainslie Parsons and Noel Courage, along with expert international coauthors, recently contributed to an article in The Patent Lawyer Magazine examining how plant breeders and biotechs can p...Read More -
Janice Bereskin and Tamara Céline Winegust discuss a key trademark ruling in Canada for the Pharmaceutical Trade Marks Group
Principals Janice Bereskin and Tamara Céline Winegust recently wrote a feature for the March 2026 edition of Spotlight from the Pharmaceutical Trade Marks Group, exploring the implications of the rece...Read More
